Exclusive-Novo’s Wegovy and Ozempic US advertising spend doubles rival Eli Lilly, data shows
By Harshita Mary Varghese and Patrick Wingrove Jan 28 (Reuters) – Novo Nordisk spent nearly $500 million on U.S. advertising…
By Harshita Mary Varghese and Patrick Wingrove Jan 28 (Reuters) – Novo Nordisk spent nearly $500 million on U.S. advertising…
(Adds Ayers full title in paragraph four) By Rory Carroll Jan 26 (Reuters) – U.S. officials helping to safeguard Americans…
By Ariba Shahid and Saad Sayeed KARACHI, Pakistan, Jan 26 (Reuters) – Pakistan’s central bank held its key policy rate…
(Corrects to remove references from Indian government statement in paragraph 1 and paragraph 5 that the deal represents a quarter…
They’ve built major gold stories before – and they’re doing it again In Today’s News Fed’s New Power to Seize…
Jan 24 (Reuters) – Delta Air Lines said on Saturday it made additional flight cancellations for Atlanta and along the U.S.…
Tech’s Key Metal Is Running Short – Here’s the Early Name Ready for It In Today’s News Tech’s Key Metal…
By Francesco Guarascio Jan 23 (Reuters) – Vietnam’s Communist Party chief To Lam, reappointed on Friday as the country’s most…
The AI Boom Runs on Real Assets-This Company Built Them Early In Today’s News Fed’s New Power to Seize Bank…
By Sriparna Roy Jan 23 (Reuters) – Novo Nordisk’s Wegovy pill was prescribed more than 18,000 times in the U.S.…